Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia

Exclusion Criteria

• •Cardiac insufficiency; Renal insufficiency; hepatic insufficiency; Total bilirubin higher than 1.5 times of upper limit of normal value; AST /ALT higher than 2.5 times of upper limit of normal value；
• •Routine Blood Test: WBC count \<3.0×109/ L; PLT count \<5×109/L ; or Hemoglobin \<100g/L；
• •Combined Pneumonia or other Severe systemic bacteria infection；
• •Severe drug allergic history or anaphylaxis to 2 or more food or medicine；
• •Other brain organic disease (eg. Brain cancer)；
• •HIV+, Tumor Markers + ；
• •Severe psychotic patients, cognitive dysfunction， or can not understand or sign the Consent Form；
• •Other severe systemic or organic disease；
• •Uncontrolled hypertension，blood pressure≥180mmHg/110 mmHg after treatment；
• •Pregnancy；
• •Enrollment in other trials in the last 3 months；
• •Other criteria the investigator consider improper for inclusion.